(Q41421578)

30 September 2017

1 reference

title

HIV accessory proteins as therapeutic targets (English)

1 reference

30 September 2017

Miller RH

1

1 reference

30 September 2017

Sarver N

series ordinal

2

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

30 September 2017

1 reference

30 September 2017

3

1 reference

30 September 2017

4

1 reference

30 September 2017

389-394

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0497-389

30 September 2017

0 references

cites work

Clinical significance of drug resistance in human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Induction of cell differentiation by human immunodeficiency virus 1 vpr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Phosphorylation of Vif and its role in HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Cytoplasmic localization of the HTLV-III 3' orf protein in cultured T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Gene therapy and immune restoration for HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

Immunopathogenesis of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Subcellular localization of the Vif protein of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef.

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FNM0497-389

7 January 2021

Identifiers

DOI

10.1038/NM0497-389

1 reference

Dimensions Publication ID

30 September 2017

0 references

1 reference